Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.78M

combined est. value

Stock	Shares	Price	Value	Weight	As of
NBIXNEUROCRINE BIOSCIENCES INC	10,386	$177.49	$1.84M	66%	2026-05-21
ALGNALIGN TECHNOLOGY INC	5,036	$185.22	$932.8K	34%	2026-05-20

NBIX

NEUROCRINE BIOSCIENCES INC

$1.84M

10,386 sh

ALGN

ALIGN TECHNOLOGY INC

$932.8K

5,036 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 1

Stock	Transaction	Date	~6mo later
NBIXNEUROCRINE BIOSCIENCES INC	Exercise — · 3,318 sh	2026-05-21	—
ALGNALIGN TECHNOLOGY INC	Exercise — · 1,745 sh	2026-05-20	—
NBIXNEUROCRINE BIOSCIENCES INC	Sell $2.15M · 15,000 sh	2025-11-25	—
NBIXNEUROCRINE BIOSCIENCES INC	Exercise $718.4K · 15,000 sh	2025-11-25	—

NBIXExercise

2026-05-21 · NEUROCRINE BIOSCIENCES INC

3,318

—

ALGNExercise

2026-05-20 · ALIGN TECHNOLOGY INC

1,745

—

NBIXSell

2025-11-25 · NEUROCRINE BIOSCIENCES INC

$2.15M

—

NBIXExercise

2025-11-25 · NEUROCRINE BIOSCIENCES INC

$718.4K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.